Topotecan exposure estimation in pediatric acute myeloid leukemia supported by LC-MS-based drug monitoring and pharmacokinetic analysis.
about
Development and validation of a liquid chromatography-tandem mass spectrometry method for topotecan determination in beagle dog plasma and its application in a bioequivalence study.Brain Delivery of Drug and MRI Contrast Agent: Detection and Quantitative Determination of Brain Deposition of CPT-Glu Using LC-MS/MS and Gd-DTPA Using Magnetic Resonance Imaging.Modern LC in therapeutic drug monitoring and diagnosis of pediatric leukemia.Mass spectrometry in the pharmacokinetic studies of anticancer natural products.
P2860
Topotecan exposure estimation in pediatric acute myeloid leukemia supported by LC-MS-based drug monitoring and pharmacokinetic analysis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Topotecan exposure estimation ...... and pharmacokinetic analysis.
@en
Topotecan exposure estimation ...... and pharmacokinetic analysis.
@nl
type
label
Topotecan exposure estimation ...... and pharmacokinetic analysis.
@en
Topotecan exposure estimation ...... and pharmacokinetic analysis.
@nl
prefLabel
Topotecan exposure estimation ...... and pharmacokinetic analysis.
@en
Topotecan exposure estimation ...... and pharmacokinetic analysis.
@nl
P2093
P50
P1476
Topotecan exposure estimation ...... g and pharmacokinetic analysis
@en
P2093
Anna Balcerska
Elżbieta Adamkiewicz-Drożyńska
Jakub Wiśniewski
Lucyna Maciejka-Kapuścińska
Maciej Niedźwiecki
P304
P356
10.1016/J.JPBA.2012.05.012
P577
2012-05-15T00:00:00Z